Literature DB >> 10579121

Treatment of severe esophageal Crohn's disease with infliximab.

T Heller1, S P James, C Drachenberg, C Hernandez, P E Darwin.   

Abstract

Esophageal ulceration with fistula is an uncommon manifestation of Crohn's disease. Typical presentation of symptomatic esophageal Crohn's disease may include dysphagia, odynophagia, weight loss, and chest discomfort. We present a patient with severe esophageal and skin involvement of Crohn's disease that was progressive despite conventional therapy including prednisone and 6-mercaptopurine. The diagnosis of Crohn's was based on the presence of typical clinical, endoscopic, and pathologic findings, including granulomas in the skin ulcer and the absence of infectious etiologies. The patient had a nearly complete resolution of her esophageal disease with a single infusion of infliximab.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579121     DOI: 10.1097/00054725-199911000-00006

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  5 in total

1.  Successful treatment of refractory esophageal Crohn's disease with infliximab.

Authors:  D S Fefferman; S A Shah; M Alsahlil; A Gelrud; K R Falchulk; R J Farrell
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

2.  Crohn's Disease: Hard to Swallow!

Authors:  Nina Nandy; Michael Gavin; David Martin; Denis McCarthy
Journal:  Dig Dis Sci       Date:  2017-09-07       Impact factor: 3.199

3.  Crohn's disease of the esophagus.

Authors:  Kim L Isaacs
Journal:  Curr Treat Options Gastroenterol       Date:  2007-02

4.  Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis.

Authors:  Dan Turner; Anne M Griffiths
Journal:  Curr Gastroenterol Rep       Date:  2009-06

Review 5.  Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis.

Authors:  Dan Turner; Anne M Griffiths
Journal:  Curr Gastroenterol Rep       Date:  2007-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.